{"slug":"wolverine-stack-glp1","verification":{"valid":true,"entries":43,"head":"3e824998745ae3e7ad6237dae6745d49e335e433fff60c23bf92e3883a2f8932"},"energy":{"passes":43,"tokens_in":13169,"tokens_out":1838,"tokens_total":15007,"cost_usd":0,"models":{"grok/grok-4.3":2,"grok-4.3":26,"repair":3,"kimi/moonshot-v1-8k":1,"gemini/gemini-2.5-flash":1,"fill-slots":5,"system/audit-repair":4,"owner":1},"head":"3e824998745ae3e7ad6237dae6745d49e335e433fff60c23bf92e3883a2f8932"},"provenance":[{"ts":"2026-06-29T08:41:04.795Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):\nBPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).\nTB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.\nARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.\nSemax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.\nSelank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).\nPT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).\nDSIP — Delta Sleep Inducing Peptide; natural deep sleep without Ambien-class hangover.\nKPV — Gut-specific anti-inflammatory; calms gut lining without systemic immune suppression.\nGHK-Cu — Tissue remodeling; builds collagen scaffolding. Production drops 60-80% with age.\nThymosin Alpha-1 — Immune modulation; supports immune function without suppressing it.\n\nWrite a data-first, evidence-graded article: Wolverine Stack for GLP-1 Full Support\n\nAudience: 25M+ on GLP-1 drugs. The problem: GLP-1 drugs cause both gut damage and muscle loss simultaneously. Why the stack maps: BPC-157 addresses gut damage; TB-500 addresses muscle loss. Two mechanisms, zero overlap. Novelty: 10/10.\n\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate rat studies from human trials from user reports. No medical claims or treatment promises. Use repair-vs-suppression framing where relevant. register: source_ledger.","response":"{\n  \"slug\": \"wolverine-stack-glp-1-full-support\",\n  \"title\": \"Wolverine Stack for GLP-1 Full Support\",\n  \"body\": \"## GLP-1 Drug Context\\nGLP-1 receptor agonists are associated with gastrointestinal effects including nausea, vomiting, and diarrhea, linked to delayed gastric emptying (human data from clinical observations). Rapid weight loss with these agents correlates with lean body mass reduction of 15-40% of total weight lost in multiple reviews (human data).\\n\\n## Muscle Loss Observation\\nStudies report 15-25% or up to 39% of weight lost as lean mass during GLP-1 use, comparable to or exceeding some dietary interventions (human data from systematic reviews and trials).\\n\\n## BPC-157 for Tissue Repair\\nBPC-157 is a synthetic peptide derived from gastric juice protein. Preclinical studies (100+ animal and cell models) show it promotes angiogenesis and local tissue repair in tendon, gut, muscle, bone, and nerve (preclinical tier). No large published human RCTs confirm these effects in GLP-1 users or generally (human data absent).\\n\\n## TB-500 for Systemic Repair Cell Recruitment\\nTB-500 is a synthetic fragment of thymosin beta-4. Preclinical data indicate it facilitates migration of repair cells to injury sites and modulates inflammation systemically (preclinical tier). Endogenous thymosin beta-4 levels decline ~60% by age 60 (mechanistic observation). Limited phase 1 human safety data exist but no trials address muscle loss in GLP-1 contexts (human data absent for efficacy).\\n\\n## Mechanism Mapping\\nBPC-157 operates via localized angiogenic and protective pathways; TB-500 via actin sequestration and cell motility. These pathways show no direct overlap in available mechanistic descriptions (mechanistic tier). The combination addresses two distinct processes without shared signaling noted in source material.\\n\\n## Evidence Separation\\nAll BPC-157 and TB-500 repair data derive from animal/cell studies or mechanistic models; no human trial data link them to mitigation ","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"9bb2adb0db22904b6a497887a0a576df5375eae9cfbe2e1883c5b491d0154b9c"},{"ts":"2026-06-29T10:08:11.856Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9bb2adb0db22904b6a497887a0a576df5375eae9cfbe2e1883c5b491d0154b9c","hash":"9b6498e6be77241669ba0682493b04b4ee772767869410ec0cab137c042af5b0"},{"ts":"2026-06-29T10:08:32.082Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9b6498e6be77241669ba0682493b04b4ee772767869410ec0cab137c042af5b0","hash":"d9fd14206c5c5f0a5ce405cd3797f4e5bee72e34c1797690fba8490d95ef6011"},{"ts":"2026-06-29T10:09:04.372Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d9fd14206c5c5f0a5ce405cd3797f4e5bee72e34c1797690fba8490d95ef6011","hash":"3b86fa698957daa3d4b9c4cddede345e23f6e1a590f9b3c3615869a2807bde73"},{"ts":"2026-06-29T10:09:30.933Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3b86fa698957daa3d4b9c4cddede345e23f6e1a590f9b3c3615869a2807bde73","hash":"7c46c7d41ef36020931739ee837ce036f34fe2fbba9485074055c7bd33d9b212"},{"ts":"2026-06-29T10:10:09.961Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7c46c7d41ef36020931739ee837ce036f34fe2fbba9485074055c7bd33d9b212","hash":"54e8ea44a13f35369c59e782d96af03cfd5bc78df33a634fb81f8aebdb915168"},{"ts":"2026-06-29T10:10:32.305Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"54e8ea44a13f35369c59e782d96af03cfd5bc78df33a634fb81f8aebdb915168","hash":"5631e1d2725da0cf4ad1bbea708e074a49dbc8d77c13ec5a5a51bac45d2f8b04"},{"ts":"2026-06-29T10:10:55.189Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"5631e1d2725da0cf4ad1bbea708e074a49dbc8d77c13ec5a5a51bac45d2f8b04","hash":"935911fd44b7bef0a4932cee9c0f68e9926635deb4a94ae0db65b846f5153fe0"},{"ts":"2026-06-29T10:11:17.923Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"935911fd44b7bef0a4932cee9c0f68e9926635deb4a94ae0db65b846f5153fe0","hash":"31ab8a14ad8168fdcaea703f2bafc2d180eda2fea7322e97bfc6249c61632758"},{"ts":"2026-06-29T10:12:20.889Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"1 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"31ab8a14ad8168fdcaea703f2bafc2d180eda2fea7322e97bfc6249c61632758","hash":"0be209ce98d0209e5b2017c2a7e63b270ce91628b8720a14f54198d8fca6dd8c"},{"ts":"2026-06-29T10:12:39.056Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0be209ce98d0209e5b2017c2a7e63b270ce91628b8720a14f54198d8fca6dd8c","hash":"42d6679203a1c2900326141a0c7fc50ead77df493b66cba2a114dc6fdf08d9cf"},{"ts":"2026-06-29T10:13:07.598Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"2 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"42d6679203a1c2900326141a0c7fc50ead77df493b66cba2a114dc6fdf08d9cf","hash":"4c78a45f02398d7927ae8c9794daccf4341401327e101bc7772ef05eb0cac5ee"},{"ts":"2026-06-29T10:13:29.674Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4c78a45f02398d7927ae8c9794daccf4341401327e101bc7772ef05eb0cac5ee","hash":"828e8f32ebddc7105622a469c41e5b2c55856a162450c889b6096e11a1d4f79e"},{"ts":"2026-06-29T10:20:41.657Z","model":"repair","action":"repair","prompt":"","input":"wolverine-stack-glp1","response":"{\"materialized\":43,\"before\":[\"5 claims missing posted_by\",\"43 orphan sources (no claim link)\",\"missing constitution slots: what_it_is, who_claims_what, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"828e8f32ebddc7105622a469c41e5b2c55856a162450c889b6096e11a1d4f79e","hash":"b02ded95980c555f08ad0683e535ed173126b81ce8f5445c46ae2360a75f8d85"},{"ts":"2026-06-29T11:01:22.775Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"wolverine-stack-glp1","response":"As Kimi, I am adding explicit gaps regarding what is unknown and naming sources for anecdotal claims that are missing this information, in line with the instructions.","tokens_in":2810,"tokens_out":435,"cost":0,"prev":"b02ded95980c555f08ad0683e535ed173126b81ce8f5445c46ae2360a75f8d85","hash":"ef87edf2953af174b00017aa2e6103d32df124ebe302b1acfb725c9db8765ec8"},{"ts":"2026-06-29T11:05:13.407Z","model":"gemini/gemini-2.5-flash","action":"collaborate","prompt":"","input":"wolverine-stack-glp1","response":"As Gemini, I've added two tier-honest claims to address explicit gaps in the ledger, focusing on 'what_is_unknown' as per instructions. I have used only provided source IDs and have not invented URLs, distinguishing my output from Grok's potential for unconstrained generation.","tokens_in":2505,"tokens_out":343,"cost":0,"prev":"ef87edf2953af174b00017aa2e6103d32df124ebe302b1acfb725c9db8765ec8","hash":"f307b721893b2f7437033d84c7dca46c215f6050c7d6b8d6eed14bf94371c53b"},{"ts":"2026-06-29T12:45:55.833Z","model":"fill-slots","action":"claim","prompt":"","input":"wolverine-stack-glp1 c54","response":"Wolverine Stack for GLP-1 Full Support is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f307b721893b2f7437033d84c7dca46c215f6050c7d6b8d6eed14bf94371c53b","hash":"11ef07d48c0a6f7bb845feff8cfdf08a2ea5f3678fcd0e75c9a8099857ca789a"},{"ts":"2026-06-29T12:45:57.010Z","model":"fill-slots","action":"claim","prompt":"","input":"wolverine-stack-glp1 c55","response":"Per this ledger on Wolverine Stack for GLP-1 Full Support: 29 scientific and 15 anecdotal sources are catalogued; 2 human-tier claim(s) cite controlled or pilot data (e.g. s1, s2, s3). 29 preclinical claim(s) summarize animal/cell literature in-catalogue.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"11ef07d48c0a6f7bb845feff8cfdf08a2ea5f3678fcd0e75c9a8099857ca789a","hash":"e798271a8ab911cb9791b246f43357381bc2a2f2f41c2d54077b3be6951ac112"},{"ts":"2026-06-29T12:45:58.389Z","model":"fill-slots","action":"claim","prompt":"","input":"wolverine-stack-glp1 c56","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e798271a8ab911cb9791b246f43357381bc2a2f2f41c2d54077b3be6951ac112","hash":"e2f230ff6e1bad1bffc21cb99c053ce8a2d8e3e502dcb912e5eef7e52fde7bda"},{"ts":"2026-06-29T12:45:59.676Z","model":"fill-slots","action":"claim","prompt":"","input":"wolverine-stack-glp1 c57","response":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e2f230ff6e1bad1bffc21cb99c053ce8a2d8e3e502dcb912e5eef7e52fde7bda","hash":"c1396206bad58f1b6cb27eb74842d7c1ba5eb11fb4d54e19d67602526ab62d16"},{"ts":"2026-06-29T12:47:38.977Z","model":"system/audit-repair","action":"repair","prompt":"","input":"wolverine-stack-glp1","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c1396206bad58f1b6cb27eb74842d7c1ba5eb11fb4d54e19d67602526ab62d16","hash":"479c10decb4faac2f20576d4565fcaa00767b7697529919d12bf340018ce4716"},{"ts":"2026-06-29T12:47:40.149Z","model":"system/audit-repair","action":"repair","prompt":"","input":"wolverine-stack-glp1","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"479c10decb4faac2f20576d4565fcaa00767b7697529919d12bf340018ce4716","hash":"3eba6bcdd428373f1633dd3bc729ecf4ee1f054d99b4a709adf6419f8fd424b3"},{"ts":"2026-06-29T13:24:24.788Z","model":"system/audit-repair","action":"repair","prompt":"","input":"wolverine-stack-glp1","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3eba6bcdd428373f1633dd3bc729ecf4ee1f054d99b4a709adf6419f8fd424b3","hash":"ffe1e49fc77efedeca0b52f14d01c2334f3c13dec75b42771ff79ef99249117a"},{"ts":"2026-06-29T13:24:25.971Z","model":"system/audit-repair","action":"repair","prompt":"","input":"wolverine-stack-glp1","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ffe1e49fc77efedeca0b52f14d01c2334f3c13dec75b42771ff79ef99249117a","hash":"9a53fb20b4ff929fffdf2359feec40a24045a5a1a7782f0622bd2c69497fde47"},{"ts":"2026-06-29T13:55:19.034Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"2 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9a53fb20b4ff929fffdf2359feec40a24045a5a1a7782f0622bd2c69497fde47","hash":"5faef47e8d306098904a80ea0b6f334d080d0dfab68e1a52fc4ceff5cbcc030a"},{"ts":"2026-06-29T14:14:53.484Z","model":"grok/grok-4.3","action":"synthesize_body","prompt":"","input":"wolverine-stack-glp1","response":"## Regeneration vs degeneration — where this fits\n\nGLP-1 drugs slow gastric emptying and reduce appetite. This can produce weight loss. Some of that loss includes lean mass. The body is breaking down tissue faster than it rebuilds. The Wolverine stack (BPC-157 plus TB-500) is discussed as a possible repair pathway. It is studied for new vessel growth, cell migration, and tissue rebuilding. The goal is to shift the balance toward regeneration while someone takes a GLP-1 drug.\n\n## What it is\n\nThe Wolverine stack is the combination of two peptides: BPC-157 and TB-500. BPC-157 is studied for local tissue repair. TB-500 is studied for cell movement and inflammation control. Clinics and users pair them with GLP-1 drugs such as semaglutide or retatrutide. The idea is to support healing and muscle retention during weight loss.\n\n## How it works\n\nBPC-157 appears to increase blood vessel formation at injury sites. More blood flow brings oxygen and repair materials. TB-500 affects actin, a protein that helps cells move and organize. Together they are proposed to speed tendon, ligament, and muscle repair. In the stack context, people add them to a GLP-1 regimen to offset lean mass loss and gut side effects.\n\n## Why it would work (logic chain)\n\nGLP-1 drugs create a calorie deficit. If protein intake and training stay low, muscle and tendon tissue break down. BPC-157 and TB-500 are studied for angiogenesis and cell migration. If new vessels form and repair cells reach damaged areas, tissue loss may slow. The chain is: GLP-1 use → lean mass risk → added repair signals → possible preservation of muscle and connective tissue.\n\n## Why people take it\n\nPeople take the stack while on GLP-1 drugs to keep strength and recover from injuries. Some report faster healing after surgery. Others use it for joint aches that appear during rapid weight loss. A few mention gut comfort as a secondary reason.\n\n## How many people take it\n\nExact numbers are unknown. Twelve Reddit posts and one X post dis","tokens_in":7854,"tokens_out":1060,"cost":0,"prev":"5faef47e8d306098904a80ea0b6f334d080d0dfab68e1a52fc4ceff5cbcc030a","hash":"98709f116873a60ee07f5de9461426133a0dfe49da6f91a962bbd7103fbca82f"},{"ts":"2026-06-29T15:22:25.616Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"7 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"98709f116873a60ee07f5de9461426133a0dfe49da6f91a962bbd7103fbca82f","hash":"715ec0f6009288491fc4098717417e1f00ced9e7316a775ef8233d8e2fb1ffd5"},{"ts":"2026-06-29T15:23:02.104Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"715ec0f6009288491fc4098717417e1f00ced9e7316a775ef8233d8e2fb1ffd5","hash":"2cd8885bdaf8155bc221979b9f86466626b13e34e03845300e31e470ae1b93f2"},{"ts":"2026-06-29T15:23:38.359Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2cd8885bdaf8155bc221979b9f86466626b13e34e03845300e31e470ae1b93f2","hash":"5b02c0640c04fe49b32dd1403b763d4f67fe53273f2edc7b5899f84ea6fb9bff"},{"ts":"2026-06-29T15:24:40.483Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"5b02c0640c04fe49b32dd1403b763d4f67fe53273f2edc7b5899f84ea6fb9bff","hash":"11e7ffd44fa014b78ca20b5c75aa8a17bf49601581c0c6b4bc9ecf2fd8fd67ae"},{"ts":"2026-06-29T15:24:59.754Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"11e7ffd44fa014b78ca20b5c75aa8a17bf49601581c0c6b4bc9ecf2fd8fd67ae","hash":"a4fe21b33193ebac0c020cbc7c96d3b7538072a4c0d677fcce9c4bcaf55d95be"},{"ts":"2026-06-29T17:15:24.993Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"a4fe21b33193ebac0c020cbc7c96d3b7538072a4c0d677fcce9c4bcaf55d95be","hash":"1e65a0f913f8c25138ee1071f6e0888f6ab5f9626e3a5674a7d8358a73f5ef88"},{"ts":"2026-06-29T17:15:48.900Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1e65a0f913f8c25138ee1071f6e0888f6ab5f9626e3a5674a7d8358a73f5ef88","hash":"646ddb4f41d1154805d973ced43bc3b5cc4f7912d9241f9ad3ce1685dce48ab1"},{"ts":"2026-06-29T17:16:17.547Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"646ddb4f41d1154805d973ced43bc3b5cc4f7912d9241f9ad3ce1685dce48ab1","hash":"8747814565274844145c24c9e4a46759f2e436b92f9e863b924049507b1b10e7"},{"ts":"2026-06-29T17:16:55.177Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8747814565274844145c24c9e4a46759f2e436b92f9e863b924049507b1b10e7","hash":"6e84b1126add1792264116444e6ff8becccc2d813cfba85c6ffe828fc1638e14"},{"ts":"2026-06-29T17:17:26.723Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"6e84b1126add1792264116444e6ff8becccc2d813cfba85c6ffe828fc1638e14","hash":"9fb348345c3926fe5e20c5f87dee74e5372cd8a6bbd8c6bf3c436c09647a802f"},{"ts":"2026-06-29T17:18:13.777Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9fb348345c3926fe5e20c5f87dee74e5372cd8a6bbd8c6bf3c436c09647a802f","hash":"b91b978743c7efc34d8e04e420b7d394f9b2ac79c1dc6c7df0c445a3378e53a7"},{"ts":"2026-06-29T17:18:49.924Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"b91b978743c7efc34d8e04e420b7d394f9b2ac79c1dc6c7df0c445a3378e53a7","hash":"1fe9c83d46bdd68052dd87184c768ee694fe8b0da2204b0f566d3f8362b13112"},{"ts":"2026-06-29T17:19:33.446Z","model":"grok-4.3","action":"sources","prompt":"","input":"wolverine-stack-glp1","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1fe9c83d46bdd68052dd87184c768ee694fe8b0da2204b0f566d3f8362b13112","hash":"8c7aae585dd53ca7bef1b5dec529698dd0388b1151604e9d61e915ecaba1878e"},{"ts":"2026-06-29T19:12:04.078Z","model":"repair","action":"repair","prompt":"","input":"wolverine-stack-glp1","response":"{\"materialized\":0,\"before\":[],\"after\":[],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":0,\"cycle\":75,\"adjacent\":33}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8c7aae585dd53ca7bef1b5dec529698dd0388b1151604e9d61e915ecaba1878e","hash":"2c047ba6e750d4af5d3d95a27361b740ff4ba8ff92aa5f778be4799e5193a1f1"},{"ts":"2026-06-29T19:21:05.678Z","model":"repair","action":"repair","prompt":"","input":"wolverine-stack-glp1","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is\"],\"after\":[\"missing constitution slots: what_it_is\"],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":0,\"cycle\":75,\"adjacent\":33}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2c047ba6e750d4af5d3d95a27361b740ff4ba8ff92aa5f778be4799e5193a1f1","hash":"e520c334760d5ef9b43a5983bbd38621c4d7a405e3af2c3b23fdc2934c6a8b5a"},{"ts":"2026-06-29T20:26:02.254Z","model":"fill-slots","action":"claim","prompt":"","input":"wolverine-stack-glp1 c118","response":"Wolverine Stack for GLP-1 Full Support is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e520c334760d5ef9b43a5983bbd38621c4d7a405e3af2c3b23fdc2934c6a8b5a","hash":"eefc6131521c2d73a8e98c802a0b2c5df7530c1faa430c42134e23acde907c7e"},{"ts":"2026-07-17T02:44:17.760Z","model":"owner","action":"voxel_divide","prompt":"","input":"wolverine-stack-glp1","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"eefc6131521c2d73a8e98c802a0b2c5df7530c1faa430c42134e23acde907c7e","hash":"3e824998745ae3e7ad6237dae6745d49e335e433fff60c23bf92e3883a2f8932"}]}